PTAB Finds MRI Machine Claims Patent-Ineligible Under Alice

Jan 19, 2017

Reading Time : 2 min

Inventors Hiroyuki Itagaki and Takashi Nishihara filed an appeal with the PTAB after a United States Patent and Trademark Office examiner rejected the claims as obvious under § 103. The panel of administrative law judges reversed the examiner’s § 103 rejections. However, the PTAB found new grounds for rejecting the claims under § 101. The application discloses an MRI machine and image classification method wherein the MRI machine classifies and rearranges multiple images, making it easier for a user to compare images. In finding the claims abstract under § 101, the PTAB applied the two-step analytical framework outlined in the Supreme Court’s decision in Alice v. CLS Bank.

The first step under Alice requires that the board examine whether the claims are directed toward a patent-ineligible concept, such as an abstract idea. Here, the claimed subject matter was directed toward image classification. The board reasoned that “[c]lassification is a building block of human ingenuity” and “[a]s such the classification concept is directed toward an abstract idea.”

The second step under Alice involves “a search for an ‘inventive concept’—i.e., an element or combination of elements that is sufficient to ensure that the patent in practice amounts to significantly more than a patent upon the ineligible concept itself.” The PTAB held that merely applying the image classification concept to an MRI machine does not make the classification concept any less abstract, stating generally that “a recitation of practical application for an abstract idea is insufficient to transform an abstract idea into an inventive concept.”

The PTAB noted that the multi-station MRI machine described by claim 1 was not otherwise patentably distinct from typical multi-station MRI machines available at the time the application was filed. The PTAB then considered the “classification processing unit,” which was described as “a classification processing unit configured to classify the plurality of images by image types and station position, based on imaging condition including imaging parameters.” The board held that, because the “unit” was described in general functional terms, the description “does little to patentably transform the classification abstract idea.”

The PTAB concluded that “[c]lassifying images is not transformed into an inventive concept by simply applying it to the images a typical multi-station MRI necessarily produces.” Accordingly, under the analytical methodology outlined by Alice, the PTAB found the clams patent-ineligible under § 101.

Ex Parte Itagaki, et al, Appeal No. 2015-002702 (PTAB Dec. 29, 2016). [Lorin (opinion), Mohanty and Meyers]

Share This Insight

Previous Entries

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.